Guinea-Bissau vs Vietnam: The number of people with susceptibility test result for rifampicin
Guinea-Bissau
89.04
in 2021
Vietnam
88.85
in 2021
Guinea-Bissau rank
70th
Vietnam rank
72nd
The number of people with susceptibility test result for rifampicin over time
- Guinea-Bissau
- Vietnam
How they compare
Guinea-Bissau currently reports 89.04 against 88.85 in Vietnam, a difference of 0.19.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Vietnam ahead.
Guinea-Bissau ranks 70th and Vietnam ranks 72nd of 146 countries.
Vietnam has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Guinea-Bissau | Vietnam | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.23 | 72.54 | 71.31 | Vietnam |
| 2020s | 73.23 | 87.14 | 13.92 | Vietnam |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Guinea-Bissau or Vietnam?
- Guinea-Bissau, at 89.04 against 88.85 in Vietnam as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Guinea-Bissau and Vietnam?
- 0.19, with Guinea-Bissau ahead.
- How many years of comparable data are there for Guinea-Bissau and Vietnam?
- 5 years are reported by both, from 2017 to 2021.
- How do Guinea-Bissau and Vietnam rank globally for the number of people with susceptibility test result for rifampicin?
- Guinea-Bissau ranks 70th and Vietnam ranks 72nd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.